The Hindu Editorial (In haste) – Apr 29, 2022

The emergency use authorisation (EUA) granted on April 26 to two COVID-19 vaccines — Corbevax for children 5-11 years, and Covaxin for children 6-11 years — is one more instance where the Indian drug regulator has acted in haste… For further reading, visit “The Hindu”. Below is today’s word list-1 for The Hindu Editorial (In haste) – Apr 29, 2022.

To read this article, click “The Hindu”.

This preview is provided here with permission.

Courtesy: The Hindu

The Hindu Editorial (In haste) – Apr 29, 2022:

in haste (phrase) – with alacrity, with urgency, in a rush, in a hurry; quickly, rapidly, speedily.
vaccinate (verb) – inoculate, administer, introduce (with a vaccine to provide immunity against a disease).
Emergency Use Authorisation (EUA) (noun) – a mechanism to facilitate the availability and use of medical countermeasures, including vaccines, during public health emergencies, such as the current COVID-19 pandemic.
vaccine (noun) – a biological preparation that improves immunity to a particular disease.
Corbevax (noun) – a COVID-19 vaccine candidate developed by Indian biopharmacutical firm Biological E. Biological E’s anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is currently undergoing phase 2/3 clinical trials on adults.
Covaxin (noun) – India’s first indigenous COVID-19 vaccine candidate (COVAXIN) developed by a Hyderabad-based company (Bharat Biotech) in collaboration with the ICMR (The Indian Council of Medical Research).
instance (noun) – occasion, occurrence, case.
drug (noun) – medicine, medication.
regulator (noun) – an association that supervises a particular business activity.
efficacy (noun) – In medicine, the ability of an intervention (for example, a drug or surgery) to produce the desired beneficial effect; effectiveness, efficiency, power.
phase-3 trial (noun) – In phase 3 trial, the vaccine is given to thousands of people to confirm its safety – including rare side effects – and effectiveness. These trials involve a control group which is given a placebo.
phase 2 trial (noun) – In phase 2 trial, the vaccine is given to hundreds of people so scientists can learn more about its safety and correct dosage.
human trial/clinical trial (noun) – a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
trial (noun) – test, pilot study, experiment (phase 1, 2,3, and or human/clinical trial).
condone (verb) – approve, sanction, justify, vindicate, endorse.
desperate (adjective) – urgent, pressing, compelling; last-ditch, last-resort, last-minute, final.
measure (noun) – action, step, procedure.
fig leaf (noun) – (figuratively) something that is used to hide an embarrassing situation or problem; disguise, camouflage, cover-up, shield, facade, veneer.
green light/green lighting (noun) – authorization, permission, approval, assent, consent.
deadly (adjective) – fatal, lethal, life-threatening.
delta variant/B.1.617.2 (noun) – Formally known as AY.2 or B.1.617.2, it’s a variant of the coronavirus, first identified in India, is renamed as the ‘Delta variant’ by the World Health Organization (WHO) and this variant is reclassified as Variant of Concern (VOC). The B.1.617.1 strain has been reclassified to a Variant of Interest (VOI) and labelled variant “Kappa”.
Omicron variant (noun) – On 26 November 2021, WHO designated the (new coronavirus) variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). The first known confirmed Omicron infection was from a specimen collected on November 9. In recent weeks, infections in South Africa have increased steeply, coinciding with the detection.
variant (noun) – different or form or version or mutant of something (virus).
Indian Council of Medical Research (ICMR) (noun) – the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world. As early as in 1911, the Government of India set up the Indian Research Fund Association (IRFA) with the specific objective of sponsoring and coordinating medical research in the country. It was redesignated in 1949 as the Indian Council of Medical Research (ICMR). The ICMR is funded by the Government of India through the Ministry of Health & Family Welfare.
seroprevalence (noun) – the number of persons in a population who test positive for a specific disease based on serology (blood serum) specimens.
novel coronavirus (nCoV) (SARS-CoV-2) (noun) – a new strain (type/variety) coronavirus that has not been previously identified in humans. (Courtesy: WHO)
vaccination (noun) – treatment with a vaccine to protect against a particular disease; immunization.
adolescent (noun) – teenager, youngster, young person.
adult (noun) – grown person, grown-up person, mature person.
antibody (noun) – it is also called ‘immunoglobulin’; a protective protein produced mainly by plasma (blood) cells in the immune system in response to the presence of antigens (disease causing organisms (bacteria & viruses) and other harmful/toxic foreign substances like insect venom).
contract (verb) – develop, catch, become infected with, fall ill with, be taken ill with (a disease).
validation (noun) – approval, endorsement, acceptance, ratification.
follow-up (noun) – result, effect, conclusion, development, end product.
necessity (noun) – essential requirement, prerequisite, indispensable item, need.
green light (verb) – authorize, permit, approve, assent to, give consent to.
preprint (noun) – a full draft of a research paper that is shared publicly before it has been peer reviewed/has been sent to press for publication.
peer reviewed (adjective) – relating to a process by which something research or publication is evaluated by a group of experts in the appropriate field.
precedent (noun) – model, exemplar, example, pattern; previous example/instance, prior instance.
seek (verb) – ask for, request, appeal for, apply for; try to obtain, aim, attempt.
National Technical Advisory Group on Immunisation (NTAGI) (noun) – The National Technical Advisory Group on Immunisation (NTAGI) was established by an order of the Ministry of Health and Family Welfare (MoHFW) in 2001. As India’s apex advisory body on immunization, the NTAGI provides guidance and advice to the MoHFW on provision of vaccination and immunization services for the effective control of vaccine preventable diseases in the country. The National Technical Advisory Group on Immunisation in India (NTAGI) fulfils a need for informing decision-making concerning the introduction of new vaccines and strengthening the Universal Immunisation Programme (UIP).
clear (verb) – authorize, permit, allow, accept, endorse, sanction, give approval to, give consent to.
immunisation (noun) – the process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine. Vaccines stimulate the body’s own immune system to protect the person against subsequent infection or disease.
likelihood (noun) – probability, chance, prospect, possibility, likeliness feasibility.
prompt (verb) – give rise to, bring about, cause, produce, result in, lead to.
sidestep (verb) – avoid, dodge, elude, circumvent, bypass, escape.
depart (verb) – deviate, diverge, digress, differ, vary, turn aside.
evidence-based (adjective) – relating to a conscientious (thorough &careful), problem-solving approach to clinical practice that incorporates the best evidence from well-designed studies, patient values and preferences, and a clinician’s expertise in making decisions about a patient’s care.
policymaking (noun) – the process of formulating policies, particularly in politics.